Insights

Digital Health Tools Ovarian Cancer Action has recently launched digital tools such as a free symptoms tracker and initiatives like Improve UK, which aim to enhance patient health monitoring and care access. This presents opportunities for partnerships in healthcare technology solutions, patient engagement platforms, and data analytics services.

Research and Innovation The organization is heavily involved in cutting-edge research, partnering with key organizations and backing innovators to improve early detection and treatment. This creates potential for collaborations with biotech firms, medical device companies, and research technology providers seeking to support or fund groundbreaking ovarian cancer solutions.

Funding Growth Potential With an estimated revenue between 1M and 10M dollars, Ovarian Cancer Action is mid-sized with ongoing funding needs for expanding programs and research. Engaging in sponsorships, donations, or grants could help support their initiatives while offering visibility within the nonprofit healthcare sector.

Partnership Opportunities The organization actively partners with other charities and community groups like the Women's Institute, Target Ovarian Cancer, and The Eve Appeal, indicating openness to new collaborations. Businesses offering community outreach, patient support, or educational content could find valuable alignment here.

Leadership and Community Engagement Recent appointments of experienced leaders and ambassadors, along with active patient and community programs, suggest a strategic focus on advocacy and public awareness. Companies specializing in advocacy software, community engagement platforms, or event sponsorships have a prime opportunity to support or enhance these efforts.

Ovarian Cancer Action Tech Stack

Ovarian Cancer Action uses 8 technology products and services including Alteryx, Adobe InDesign, StayWell, and more. Explore Ovarian Cancer Action's tech stack below.

  • Alteryx
    Advanced Analytics And Data Science
  • Adobe InDesign
    Cad & Graphics
  • StayWell
    Healthcare Marketing
  • UPS
    Logistics
  • Frederick
    Marketing Automation
  • PWA
    Miscellaneous
  • Adobe Creative Suite
    Visualisation Software
  • Apache
    Web Servers

Media & News

Ovarian Cancer Action's Email Address Formats

Ovarian Cancer Action uses at least 1 format(s):
Ovarian Cancer Action Email FormatsExamplePercentage
First.Last@ovarian.org.ukJohn.Doe@ovarian.org.uk
62%
First@ovarian.org.ukJohn@ovarian.org.uk
28%
First-Last@ovarian.org.ukJohn-Doe@ovarian.org.uk
6%
FirstLast@ovarian.org.ukJohnDoe@ovarian.org.uk
4%

Frequently Asked Questions

Where is Ovarian Cancer Action's headquarters located?

Minus sign iconPlus sign icon
Ovarian Cancer Action's main headquarters is located at 240 City Road London, England ec1v 2pr United Kingdom. The company has employees across 1 continents, including Europe.

What is Ovarian Cancer Action's phone number?

Minus sign iconPlus sign icon
You can contact Ovarian Cancer Action's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ovarian Cancer Action's official website and social media links?

Minus sign iconPlus sign icon
Ovarian Cancer Action's official website is ovarian.org.uk and has social profiles on LinkedIn.

What is Ovarian Cancer Action's NAICS code?

Minus sign iconPlus sign icon
Ovarian Cancer Action's NAICS code is 813 - Religious, Grantmaking, Civic, Professional, and Similar Organizations.

How many employees does Ovarian Cancer Action have currently?

Minus sign iconPlus sign icon
As of April 2026, Ovarian Cancer Action has approximately 35 employees across 1 continents, including Europe. Key team members include Ceo: G. W.Non Executive Director: A. M.Director Of Research And Policy: M. P.. Explore Ovarian Cancer Action's employee directory with LeadIQ.

What industry does Ovarian Cancer Action belong to?

Minus sign iconPlus sign icon
Ovarian Cancer Action operates in the Non-profit Organizations industry.

What technology does Ovarian Cancer Action use?

Minus sign iconPlus sign icon
Ovarian Cancer Action's tech stack includes AlteryxAdobe InDesignStayWellUPSFrederickPWAAdobe Creative SuiteApache.

What is Ovarian Cancer Action's email format?

Minus sign iconPlus sign icon
Ovarian Cancer Action's email format typically follows the pattern of First.Last@ovarian.org.uk. Find more Ovarian Cancer Action email formats with LeadIQ.

When was Ovarian Cancer Action founded?

Minus sign iconPlus sign icon
Ovarian Cancer Action was founded in 2006.

Ovarian Cancer Action

Non-profit OrganizationsEngland, United Kingdom11-50 Employees

We are the game-changers in ovarian cancer. We lead lifesaving research breakthroughs for every woman.

We back researchers looking for ways to find cancer early. We team up with clinicians trialling new treatments. And, with our inspiring community, we campaign for equal access to treatment for women of every age, race and postcode.

In the UK only 1 in 3 women live more than 10 years after diagnosis. Ovarian Cancer Action wants to change this.

We are working to better prevent, treat and detect ovarian cancer. So that by 2032 at least half of women with ovarian cancer live for 10 years.

We are Ovarian Cancer Action and we’ll be here until no woman dies of ovarian cancer.

Section iconCompany Overview

Headquarters
240 City Road London, England ec1v 2pr United Kingdom
Phone number
NAICS Code
813 - Religious, Grantmaking, Civic, Professional, and Similar Organizations
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Ovarian Cancer Action's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Ovarian Cancer Action's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.